Literature DB >> 24478019

Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.

Mi-Jung Jun1, Ju Hyun Shim, So Yeon Kim, Nieun Seo, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Eunsil Yu, Sung-Gyu Lee.   

Abstract

The role of liver biopsy in selecting optimal donors is an area of continuing controversy in living donor liver transplantation (LDLT). Our aim was to assess the potential implications of preoperative and intraoperative biopsies for evaluating donor liver fat content. Three thousand eight hundred fifty-nine consecutive subjects underwent predonation needle biopsy of the right lobe, and 1766 of these subjects actually donated their livers for LDLT and underwent intraoperative wedge biopsies of paired right and left lobes. The preoperative workup protocol also included abdominal ultrasonography (USG) and computed tomography (CT). Intersample agreement on steatosis grades (<5%, 5% to <15%, 15% to <30%, and ≥30%) was calculated, and clinicometabolic factors related to sampling variability were evaluated. For detecting ≥30% steatosis in the 3859 potential donors, USG and CT had sensitivities of 84.9% and 57.3%, specificities of 76.3% and 92.7%, positive predictive values of 29.6% and 48.0%, and negative predictive values of 97.7% and 94.8%, respectively. Analyses of the 1766 actual donors showed that with respect to the total steatosis grades of intraoperative right and left biopsies versus preoperative biopsy, 36.7% and 36.0% of the pairs, respectively, differed from the weighted κ values of 0.44 and 0.40. Similar agreement levels existed for macrovesicular and microvesicular steatosis subtypes. The per-subject agreement rate for the total steatosis grade between intraoperative right and left biopsies was 83.6%. According to a multivariate analysis, independent factors affecting the variability of the total steatosis results from preoperative and intraoperative biopsies (major features) were higher systolic blood pressure, body mass index, and alanine aminotransferase values and lower high-density lipoprotein cholesterol values. In conclusion, imaging may be insufficiently sensitive for evaluating donor hepatic steatosis. Preoperative and selective intraoperative liver biopsies are mandatory for assessing donor steatosis in LDLT unless preoperative imaging demonstrates no fat.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24478019     DOI: 10.1002/lt.23832

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

1.  "No go" donor hepatectomy in living-donor liver transplantation.

Authors:  Viniyendra Pamecha; Kishore G S Bharathy; Shyam S Mahansaria; Piyush K Sinha; Archana Rastogi; Shridhar V Sasturkar
Journal:  Hepatol Int       Date:  2017-11-24       Impact factor: 6.047

Review 2.  NAFLD and liver transplantation: Current burden and expected challenges.

Authors:  Raluca Pais; A Sidney Barritt; Yvon Calmus; Olivier Scatton; Thomas Runge; Pascal Lebray; Thierry Poynard; Vlad Ratziu; Filomena Conti
Journal:  J Hepatol       Date:  2016-07-30       Impact factor: 25.083

Review 3.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

4.  Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience.

Authors:  Yafei He; Xinyan Zhao; Jimin Liu; Qian Zhang; Liwei Liu; Wei Qu; Ying Liu; Zhigui Zeng; Haiming Zhang; Jidong Jia; Liying Sun; Lin Wei; Zhijun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 5.  Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

Authors:  Naga Swetha Samji; Rajiv Heda; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

Review 6.  Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

Authors:  Ivana Mikolasevic; Tajana Filipec-Kanizaj; Maja Mijic; Ivan Jakopcic; Sandra Milic; Irena Hrstic; Nikola Sobocan; Davor Stimac; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

7.  Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor.

Authors:  Dong-Jing Yang; Ji-Hua Shi; Zong-Ping Xia; Wen-Zhi Guo; Mohammed Shakil Ahmed; Shui-Jun Zhang
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

8.  Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.

Authors:  Jong Man Kim; Sang Yun Ha; Jae-Won Joh; Dong Hyun Sinn; Woo Kyung Jeong; Gyu-Seong Choi; Geum Youn Gwak; Choon Hyuck David Kwon; Young Kon Kim; Yong Han Paik; Joon Hyeok Lee; Won Jae Lee; Suk-Koo Lee; Cheol Keun Park
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.

Authors:  Chia-En Hsieh; Kuo-Hua Lin; Ya-Lan Hsu; Chen-Te Chou; Chia-Bang Chen; Ping-Yi Lin; Chia-Cheng Lin; Yu-Ju Hung; Li-Chueh Weng; Yao-Li Chen
Journal:  Ann Transplant       Date:  2020-03-10       Impact factor: 1.530

10.  Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing.

Authors:  James A Rioux; Miriam Hewlett; Christa Davis; Chris V Bowen; Kimberly Brewer; Sharon E Clarke; Steven D Beyea
Journal:  NMR Biomed       Date:  2020-01-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.